Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Lofacimig, an antibody targeting F11.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Itanistomig, an antibody targeting PD-L1 × IAP.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Indematug, an antibody targeting IFNG.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Imeroprubart, an antibody targeting FCGRT.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Gacovetug, an antibody targeting F4+ ETEC (Veterinary Application).

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Bulumtatug, an antibody targeting LAG-3.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Birinkibart, an antibody targeting CSF2RB.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Armocibart, an antibody targeting TFPI.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Amtabafusp, an antibody targeting CD3E.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Alpitatug, an antibody targeting KLK2.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Trinbelimab, an antibody targeting RhD.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Rolistobart, an antibody targeting LILRB4.